WebMay 15, 2014 · One cell therapy to treat them all–or at least over 120 different diseases. Garuda Therapeutics is one step closer to tackling … WebSep 7, 2024 · Contact Information Website www.garudatx.com Ownership Status Privately Held (backing) Financing Status Venture Capital-Backed Primary Industry Drug Discovery Other Industries Biotechnology Primary Office 215 First Street Suites 340-350 Cambridge, MA 02142 United States Garuda Therapeutics Timeline 2024 2024
Marie Goulard - Senior Director of Research and …
WebSep 23, 2024 · CAMBRIDGE, Mass.-- ( BUSINESS WIRE )-- Garuda Therapeutics, a company creating off-the-shelf, durable blood stem cell therapies, launched today with an oversubscribed $72 million Series A financing led by Aisling Capital, Northpond Ventures and Orbimed, supported by Cormorant Asset Management, Ridgeback Capital … WebMar 5, 2024 · At Garuda Therapeutics, we are working together to develop cell therapies for patients with hematologic disorders. Over the last months, we have built a culture that is based on trust, transparency, and results. From the very beginning, we have established channels of open communication and trust-based relationships within our teams. sage dental wesley chapel fl
Garuda Therapeutics Raises $72M in Series A Financing - FinSMEs
WebSep 7, 2024 · CAMBRIDGE, Mass., September 07, 2024 -- ( BUSINESS WIRE )--Garuda Therapeutics (Garuda), a company creating off-the-shelf, durable blood stem cell therapies, today announced the appointment of ... WebGaruda Therapeutics is pioneering the development of off-the-shelf hematopoietic stem cell (HSC)-based cellular therapies for treating patients with blood, bone marrow, immune, and metabolic ... WebLegal Name Garuda Therapeutics, Inc. Company Type For Profit. Contact Email [email protected]. Garuda Therapeutics develops off-the-shelf hematopoietic stem cell therapies to treat life-threatening diseases. It seeks to create a world that eliminates the … thhn in ent